Jim Cramer's Mad Money Stock Recap Dec. 10th
Triple-S Management (GTS)
True success stories on The Street may be harder to find these days, but Cramer has observed the progress of non-profit Blue Cross Blue Shield companies that turn into public for-profit companies and found in their first four years the stocks had increased an average of 28%. He would consider Triple-S Management (GTS) which went public last week and has yet to set the sector on fire, since it opened only 16 cents above its $14.50 and undershot its projected range of $16-$18. Cramer said the companies contracts will become profitable and warned investors to do homework before buying and to use limit orders.
CEO Interview: Jack Cumming Hologic (HOLX)
Cramer likes HOLX for its visibility, growth and clean balance sheet and asked Jack Cumming about the merger with Cytic which was closed on Oct 22 and is running ahead of schedule. Cumming discussed the company's $1.3 billion convertible bond offering as a strategy to eliminate debt. Concerning competitors, He noted HOLX entered the scene two years behind its main rivals and is nine months ahead on the race for digital mammography. "We believe that when you have nine No 1. products, you're expected to grow at a fantastic rate," Cumming said.
Live with Regis' Portfolio: JDS Uniphase (JDSU), Time Warner (TWX), Advanced Micro Devices (AMD), LSI Logic (LSI), Unisys (UIS), Freeport-McMoRan (FCX), McDonald's (MCD), CVS Caremark (CVS), Oceaneering (OII), Transocean (RIG), Chevron (CVX)
Regis told viewers not to worry about holiday retail sales, since people are lining up outside stores, and Cramer reviewed Regis' portfolio. First, he told Regis he missed the ideal opportunity to sell Time Warner, which rose recently, and would sell it now. He also told Regis to sell AMD, since the company is having trouble with its next chip and has Hector Ruiz at the helm. The ticker JDSU stands for "just don't sue us," said Cramer and he told Regis to sell. He gave LSI a "tepid buy" and added "it has a shot at coming back," but Cramer told Regis Unisys was one big "house of pain." Cramer suggested Regis replace these names with FCS, MCD, CVS, OII, RIG and CVX.
Teledyne Technologies (TDY), Ansys (ANSS)
Cramer says TDY and ANSS are two "Upod artists" that overpromise and underdeliver; "Upod works because the bedrock predictor is the trumping of earnings estimates," he said. TDY is tapped into aerospace and oil, has exceeded estimates an average of 15% per quarter, has made smart acquisitions and is cheap, but Cramer would wait for it to dip before buying. Ansys is the "market leader" in simulation and software, has strong overseas exposure, 68% return business and has exceeded estimates 40 consecutive times. The stock may seem expensive, but it is growing at an impressive 19% and should be trading at a higher multiple.
Published By SeekingAlpha
True success stories on The Street may be harder to find these days, but Cramer has observed the progress of non-profit Blue Cross Blue Shield companies that turn into public for-profit companies and found in their first four years the stocks had increased an average of 28%. He would consider Triple-S Management (GTS) which went public last week and has yet to set the sector on fire, since it opened only 16 cents above its $14.50 and undershot its projected range of $16-$18. Cramer said the companies contracts will become profitable and warned investors to do homework before buying and to use limit orders.
CEO Interview: Jack Cumming Hologic (HOLX)
Cramer likes HOLX for its visibility, growth and clean balance sheet and asked Jack Cumming about the merger with Cytic which was closed on Oct 22 and is running ahead of schedule. Cumming discussed the company's $1.3 billion convertible bond offering as a strategy to eliminate debt. Concerning competitors, He noted HOLX entered the scene two years behind its main rivals and is nine months ahead on the race for digital mammography. "We believe that when you have nine No 1. products, you're expected to grow at a fantastic rate," Cumming said.
Live with Regis' Portfolio: JDS Uniphase (JDSU), Time Warner (TWX), Advanced Micro Devices (AMD), LSI Logic (LSI), Unisys (UIS), Freeport-McMoRan (FCX), McDonald's (MCD), CVS Caremark (CVS), Oceaneering (OII), Transocean (RIG), Chevron (CVX)
Regis told viewers not to worry about holiday retail sales, since people are lining up outside stores, and Cramer reviewed Regis' portfolio. First, he told Regis he missed the ideal opportunity to sell Time Warner, which rose recently, and would sell it now. He also told Regis to sell AMD, since the company is having trouble with its next chip and has Hector Ruiz at the helm. The ticker JDSU stands for "just don't sue us," said Cramer and he told Regis to sell. He gave LSI a "tepid buy" and added "it has a shot at coming back," but Cramer told Regis Unisys was one big "house of pain." Cramer suggested Regis replace these names with FCS, MCD, CVS, OII, RIG and CVX.
Teledyne Technologies (TDY), Ansys (ANSS)
Cramer says TDY and ANSS are two "Upod artists" that overpromise and underdeliver; "Upod works because the bedrock predictor is the trumping of earnings estimates," he said. TDY is tapped into aerospace and oil, has exceeded estimates an average of 15% per quarter, has made smart acquisitions and is cheap, but Cramer would wait for it to dip before buying. Ansys is the "market leader" in simulation and software, has strong overseas exposure, 68% return business and has exceeded estimates 40 consecutive times. The stock may seem expensive, but it is growing at an impressive 19% and should be trading at a higher multiple.
Published By SeekingAlpha
Labels: AMD, ANSS, CVS, CVX, FCX, GTS, HOLX, JDSU, Jim Cramer, LSI, Mad Money, MCD, OII, RIG, TDY, TWX, UIS
posted by Stock Administrator @ 7:02 AM
0 Comments
